TrialWorld journal of surgical oncology2018

Evaluation of tumor M2-pyruvate kinase (Tumor M2-PK) as a biomarker for pancreatic cancer.

Indika A Bandara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.